| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $57K | +0.1% | +4.4% |
| SG&A Expense | $407K | -27.6% | +47.6% |
| Operating Income | -$407K | +27.6% | -47.6% |
| Interest Expense | $14K | -4.7% | -37.5% |
| Pre-tax Income | -$430K | +25.5% | -43.7% |
| Net Income | -$430K | +25.5% | -43.7% |
| EPS (Diluted) | -$0.01 | +50.0% | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $177K | +21.3% | +2094.4% |
| Total Assets | $177K | +21.3% | +740.1% |
| Current Liabilities | $1.1M | -11.4% | -49.1% |
| Total Liabilities | $1.1M | -11.4% | -49.1% |
| Stockholders' Equity | -$891K | +15.9% | +57.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$594K | -206.8% | — |
| Financing Cash Flow | $652K | +150.7% | — |